TickerFacts.

Zhengye Biotechnology Holding Ltd (ZYBT): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

12.32M CNY
Year ended 2025-12-31
40.79M CNY2022-12-31: -9.99M CNY2023-12-31: 40.79M CNY2024-12-31: 27.46M CNY2025-12-31: 12.32M CNY12.32M CNY
2022-12-31 Free Cash Flow (CNY) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-3112.32M CNY-55.1%2026-04-28, From 2025-01-01
2024-12-3127.46M CNY-32.7%2026-04-28, From 2024-01-01
2023-12-3140.79M CNYn/m2026-04-28, From 2023-01-01
2022-12-31-9.99M CNYn/a2025-07-03, From 2022-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-3112.32M CNY-55.1%
Yatsen Holding Ltd (YSG)2025-12-31-136.73M CNYn/m

Compare ZYBT, YSG side by side · Screen every company in Pharmaceutical Preparations ↗